Image Source: Business Standard
India's market regulator SEBI has approved the IPOs of three various firms—VeeDa Clinical Research, SeedWorks International, and LCC Projects—clearing the way for a frenetic fundraising season in healthcare, agriculture, and infrastructure sectors.
VeeDa Clinical Research Ltd
-
CX Partners invested in CRO company to raise up to INR 185 crore through fresh issue and offer for sale of 13 million equity shares
-
Will be used in equipment upgrade, investment in Bioneeds India subsidiary, payment of debts, and digitalization
-
Operates seven facilities in India with access to 558 worldwide clinical sites; has conducted 31,000+ audits with 436 active clients
SeedWorks International Ltd
-
Hyderabad R&D seed firm to offer up to 51.97 million equity shares through offer for sale
-
Promoters are True North Fund V LLP and South Asia Growth Fund II Holdings LLC
-
Has hybrid rice, cotton, millet, and vegetable seed knowledge; with increasing coverage in Africa and Southeast Asia
-
SRISHTEe ESG initiatives based on the framework with carbon, water, and nitrogen efficiency focus
LCC Projects Ltd
-
EPC contractor of water supply and irrigation to raise INR 320 crore through fresh issue and OFS of 22.94 million shares
-
Present in 11 states with highlight projects like Sondwa Lift and Gandhi Sagar schemes
-
FY24 revenue of INR 2,438.91 crore; PAT of INR 121.99 crore; order book size of INR 7,347.42 crore
Sources: SEBI, IPO Central, Veeda Clinical Research, SeedWorks International, LCC Projects Ltd.
Advertisement
Advertisement